Two Sigma Investments’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.35M Buy
1,081,784
+535,098
+98% +$3.9M 0.01% 1542
2025
Q4
$3.35M Buy
546,686
+457,467
+513% +$4.94M 0.01% 2060
2025
Q3
$1.64M Buy
89,219
+2,857
+3% +$45.9K ﹤0.01% 2259
2025
Q2
$1.12M Buy
86,362
+49,007
+131% +$580K ﹤0.01% 2176
2025
Q1
$396K Buy
37,355
+9,795
+36% +$155K ﹤0.01% 2616
2024
Q4
$468K Buy
27,560
+10,430
+61% +$196K ﹤0.01% 2568
2024
Q3
$398K Buy
17,130
+3,812
+29% +$81.5K ﹤0.01% 2566
2024
Q2
$324K Sell
13,318
-942
-7% -$28.6K ﹤0.01% 2562
2024
Q1
$482K Sell
14,260
-11,400
-44% -$404K ﹤0.01% 2355
2023
Q4
$809K Buy
25,660
+5,100
+25% +$121K ﹤0.01% 2201
2023
Q3
$525K Buy
20,560
+500
+2% +$15.4K ﹤0.01% 2253
2023
Q2
$575K Buy
20,060
+8,600
+75% +$234K ﹤0.01% 2273
2023
Q1
$275K Buy
+11,460
New +$206K ﹤0.01% 2460
2021
Q4
Sell
-7,444
Closed -$356K 4263
2021
Q3
$356K Sell
7,444
-318,049
-98% -$14.3M ﹤0.01% 3531
2021
Q2
$11M Sell
325,493
-67,210
-17% -$2.28M 0.03% 739
2021
Q1
$16.2M Buy
392,703
+229,613
+141% +$13.7M 0.05% 510
2020
Q4
$7.08M Sell
163,090
-113,228
-41% -$7.67M 0.02% 746
2020
Q3
$11.9M Buy
276,318
+183,572
+198% +$9.11M 0.05% 453
2020
Q2
$4.33M Buy
92,746
+69,704
+303% +$2.4M 0.02% 706
2020
Q1
$313K Sell
23,042
-52,620
-70% -$673K ﹤0.01% 2271
2019
Q4
$822K Buy
75,662
+60,868
+411% +$637K ﹤0.01% 2366
2019
Q3
$152K Buy
+14,794
New +$160K ﹤0.01% 3243
2017
Q3
Sell
-3,186
Closed -$25K 2735
2017
Q2
$25K Buy
3,186
+100
+3% +$805 ﹤0.01% 2898
2017
Q1
$25K Buy
+3,086
New +$28.6K ﹤0.01% 2827
2015
Q1
Sell
-4,303
Closed -$112K 2616
2014
Q4
$112K Buy
+4,303
New +$137K ﹤0.01% 2124

Other funds holding ARCT